Reports for HOFFMANN-LA ROCHE LIMITED

Company Name

HOFFMANN-LA ROCHE LIMITED

Totals

Shortage reports

11

Actual shortage: 2 (18%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (45%)
Resolved: 4 (36%)

Discontinuation Reports

6

To be discontinued: 1 (17%)
Discontinued: 5 (83%)
Reversed: 0 (0%)

Late reports

1 (6%)

Overdue reports

1 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACTEMRA 80MG SOLUTION Avoided shortage 2021-08-20 2022-07-20 144365
ACTEMRA 200MG SOLUTION Resolved 2021-08-23 2021-12-10 144437
ACTEMRA 200MG SOLUTION Avoided shortage 2022-02-17 2022-07-20 155146
ACTEMRA 400MG SOLUTION Avoided shortage 2021-08-23 2022-07-20 144440
ACTEMRA 162MG SOLUTION Resolved 2021-07-13 2021-11-26 142457
ACTEMRA 162MG SOLUTION Actual shortage 2022-03-31 2022-07-21 157625
ACTEMRA 162MG SOLUTION Avoided shortage 2021-07-12 2021-11-25 142322
ACTEMRA 162MG SOLUTION Actual shortage 2022-03-04 2022-07-21 156092
ESBRIET 267MG TABLET Resolved 2021-04-20 2021-06-01 137715
TAMIFLU 6MG POWDER FOR SUSPENSION Avoided shortage 2018-02-08 2018-02-28 39146
TAMIFLU 6MG POWDER FOR SUSPENSION Resolved 2020-02-13 2020-04-21 105912

Showing 1 to 11 of 11

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
INVIRASE 500MG TABLET Discontinued 2021-01-20 2021-01-20 132101
INVIRASE - CAP 200MG 200MG CAPSULE To be discontinued 2018-06-28 2018-06-28 53093
LECTOPAM TAB 3MG 3MG TABLET Discontinued 2017-08-29 2018-04-03 20572
LECTOPAM TAB 6MG 6MG TABLET Discontinued 2017-08-28 2018-04-03 20448
NUTROPIN AQ PEN CARTRIDGE 10MG SOLUTION Discontinued 2017-06-30 2018-01-04 14451
PEGASYS 180MCG SOLUTION Discontinued 2017-06-30 2018-01-04 14456

Showing 1 to 6 of 6